CLINICAL NEWS
Throughout the four-week induction, the study’s participants reported moderate to severe levels of fatigue (56%),
dysgeusia (44%), difficulty sleeping (38%), dry mouth
(37%), and reduced appetite (35%).
Although patients were receiving standard supportive
care, moderate to severe symptoms were still present –
most prominently in the second and third weeks of G&VF